Raymond James & Associates Penumbra Inc Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Penumbra Inc stock. As of the latest transaction made, Raymond James & Associates holds 10,652 shares of PEN stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,652
Previous 13,368
20.32%
Holding current value
$2.58 Million
Previous $2.41 Million
14.01%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding PEN
# of Institutions
375Shares Held
29.1MCall Options Held
305KPut Options Held
192K-
Black Rock Inc. New York, NY4.26MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.68MShares$890 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.99MShares$480 Million0.04% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.55MShares$375 Million1.9% of portfolio
-
State Street Corp Boston, MA1.24MShares$299 Million0.01% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $9.17B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...